Alpha-synuclein spreading in Parkinson’s disease

Frontiers in Neuroanatomy

Volumn 8, Issue DEC, 2014, Pages

  Recasens, Ariadna ^a,d   Dehay, Benjamin ^b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CNRS   (France)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Aggregation; Neurodegenerative diseases; Parkinson disease; Spreading; synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DYNAMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HUNTINGTIN; ROTENONE; TAR DNA BINDING PROTEIN; TAU PROTEIN;

BRAIN REGION; COLLAGEN FIBRIL; DEMENTIA; ENDOCYTOSIS; GRAFT RECIPIENT; HIPPOCAMPUS; HISTOPATHOLOGY; HOST TO GRAFT TRANSMISSION; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; LEWY BODY; LYSOSOME; MEDULLA OBLONGATA; MICROGLIA; MOLECULAR BIOLOGY; MOTOR DYSFUNCTION; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FOLDING; REVIEW; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; SYNAPSE; TRANSPLANTATION;

EID: 84919424987     PISSN: None     EISSN: 16625129     Source Type: Journal    
DOI: 10.3389/fnana.2014.00159     Document Type: Review

References (96)

1. Abeliovich, A., Schmitz, Y., Farinas, I., Choi-Lundberg, D., Ho, W. H., Castillo, P. E.,et al. (2000). Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25, 239-252. doi: 10.1016/S0896-6273(00)80886-7
2. Ahn, K. J., Paik, S. R., Chung, K. C., and Kim, J. (2006). Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J. Neurochem. 97, 265-279. doi: 10.1111/j.1471-4159.2006.03731.x
3. Alafuzoff, I., Ince, P. G., Arzberger, T., Al-Sarraj, S., Bell, J., Bodi, I.,et al. (2009). Staging/typing of lewy body related alpha-synuclein pathology: a study of the brainnet Europe consortium. Acta Neuropathol. 117, 635-652. doi: 10.1007/s00401-009-0523-2
4. Alvarez-Erviti, L., Couch, Y., Richardson, J., Cooper, J. M., and Wood, M. J. (2011a). Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line. Neurosci. Res. 69, 337-342. doi: 10.1016/j.neures.2010.12.020
5. Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J.,et al. (2011b). Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol. Dis. 42, 360-367. doi: 10.1016/j.nbd.2011.01.029
6. Appel-Cresswell, S., Vilarino-Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B.,et al. (2013). Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov. Disord. 28, 811-813. doi: 10.1002/mds.25421
7. Athanassiadou, A., Voutsinas, G., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A.,et al. (1999). Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.Am. J. Hum. Genet. 65, 555-558. doi: 10.1086/302486
8. Auluck, P. K., Caraveo, G., and Lindquist, S. (2010). Alpha-synuclein: membrane interactions and toxicity in Parkinson's disease. Annu. Rev. Cell Dev. Biol. 26, 211-233. doi: 10.1146/annurev.cellbio.042308.113313
9. Beekes, M., Thomzig, A., Schulz-Schaeffer, W. J., and Burger, R. (2014). Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol. 128, 463-476. doi: 10.1007/s00401-014-1324-9
10. Bloch, A., Probst, A., Bissig, H., Adams, H., and Tolnay, M. (2006). Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol. Appl. Neurobiol. 32, 284-295. doi: 10.1111/j.1365-2990.2006.00727.x
11. Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D.,et al. (2000). Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 287, 65-67. doi: 10.1016/S0304-3940(00)01153-8
12. Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B.,et al. (2013). Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4:2575. doi: 10.1038/ncomms3575
13. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211. doi: 10.1016/S0197-4580(02)00065-9
14. Brundin, P., Li, J. Y., Holton, J. L., Lindvall, O., and Revesz, T. (2008). Research in motion: the enigma of Parkinson's disease pathology spread. Nat. Rev. Neurosci. 9, 741-745. doi: 10.1038/nrn2477
15. Burke, R. E., Dauer, W. T., and Vonsattel, J. P. (2008). A critical evaluation of the braak staging scheme for Parkinson's disease. Ann. Neurol. 64, 485-491. doi: 10.1002/ana.21541
16. Burre, J., Sharma, M., and Sudhof, T. C. (2014). Alpha-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. U.S.A. 111, E4274-E4283. doi: 10.1073/pnas.1416598111
17. Cabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L.,et al. (2002). Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797-8807.
18. Chandra, S., Gallardo, G., Fernandez-Chacon, R., Schluter, O. M., and Sudhof, T. C. (2005). Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383-396. doi: 10.1016/j.cell.2005.09.028
19. Chen, R. H., Wislet-Gendebien, S., Samuel, F.,Visanji, N. P., Zhang, G., Marsilio, D.,et al. (2013). Alpha-synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity. J. Biol. Chem. 288, 7438-7449. doi: 10.1074/jbc.M112.439497
20. Chinta, S. J., Mallajosyula, J. K., Rane, A., and Andersen, J. K. (2010). Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett.486, 235-239. doi: 10.1016/j.neulet.2010.09.061
21. Choi, J. M., Woo, M. S., Ma, H. I., Kang, S. Y., Sung, Y. H., Yong, S. W.,et al. (2008). Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9, 263-269. doi: 10.1007/s10048-008-0138-0
22. Cicchetti, F., Lacroix, S., Cisbani, G., Vallieres, N., Saint-Pierre, M., St-Amour, I.,et al. (2014). Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann. Neurol. 76, 31-42. doi: 10.1002/ana.24174
23. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B.,et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. doi: 10.1126/science.1129462
24. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A.,et al. (2007). Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220-9232. doi: 10.1523/JNEUROSCI.2617-07.2007
25. Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G., and Hengerer, B. (2009). Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J. Neurochem. 111, 192-203. doi: 10.1111/j.1471-4159.2009.06324.x
26. Danzer, K. M., Ruf, W. P., Putcha, P., Joyner, D., Hashimoto, T., Glabe, C.,et al. (2011). Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326-336. doi: 10.1096/fj.10-164624
27. Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L.,et al. (2009). Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U.S.A. 106, 13010-13015. doi: 10.1073/pnas.0903691106
28. Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., and Anandatheerthavarada, H. K. (2008). Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100. doi: 10.1074/jbc.M710012200
29. DeWitt, D. C., and Rhoades, E. (2013). Alpha-synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry 52, 2385-2387. doi: 10.1021/bi4002369
30. Dickson, D. W. (2012). Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect. Med.2:a009258. doi: 10.1101/cshperspect.a009258
31. Dickson, D. W., Uchikado, H., Fujishiro, H., and Tsuboi, Y. (2010). Evidence in favor of Braak staging of Parkinson's disease. Mov. Disord. 25(Suppl. 1), S78-S82. doi: 10.1002/mds.22637
32. El-Agnaf, O. M., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J.,et al. (2003). Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.FASEB J. 17, 1945-1947. doi: 10.1096/fj.03-0098fje
33. Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H.,et al. (2010). Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30, 6838-6851. doi: 10.1523/JNEUROSCI.5699-09.2010
34. Gelpi, E., Navarro-Otano, J., Tolosa, E., Gaig, C., Compta, Y., Rey, M. J.,et al. (2014). Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov. Disord. 29, 1010-1018 doi: 10.1002/mds.25776
35. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S.,Su, L.,et al. (2008). The Parkinson's disease protein alpha-synuclein disrupts cellular rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105, 145-150. doi: 10.1073/pnas.0710685105
36. Gousset, K., Schiff, E., Langevin, C., Marijanovic, Z., Caputo, A., Browman, D. T.,et al. (2009). Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11, 328-336. doi: 10.1038/ncb1841
37. Guardia-Laguarta, C., Area-Gomez, E., Rub, C., Liu, Y., Magrane, J., Becker, D.,et al. (2014). Alpha-synuclein is localized to mitochondria-associated ER membranes. J. Neurosci. 34, 249-259. doi: 10.1523/JNEUROSCI.2507-13.2014
38. Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B.,et al. (2013). Distinct alpha-synuclein strains differentially promote tau inclusions in neurons. Cell 154, 103-117. doi: 10.1016/j.cell.2013.05.057
39. Guo, J. L., and Lee, V. M. (2014). Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases.Nat. Med. 20, 130-138. doi: 10.1038/nm.3457
40. Halliday, G., McCann, H., and Shepherd, C. (2012). Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? Expert Rev. Neurother. 12, 673-686. doi: 10.1586/ern.12.47
41. Hansen, C., Angot, E., Bergstrom, A. L., Steiner, J. A., Pieri, L., Paul, G.,et al. (2011). Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest.121, 715-725. doi: 10.1172/JCI43366
42. Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Bjorklund, T.,et al. (2014). Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 128, 805-820. doi: 10.1007/s00401-014-1343-6
43. Irwin, D. J., Abrams, J. Y., Schonberger, L. B., Leschek, E. W., Mills, J. L., Lee, V.,et al. (2013). Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol. 70, 462-468. doi: 10.1001/jamaneurol.2013.1933
44. Jenco, J. M., Rawlingson, A., Daniels, B., and Morris, A. J. (1998). Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Biochemistry 37, 4901-4909. doi: 10.1021/bi972776r
45. Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B.,et al. (2010). Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29, 3571-3589. doi: 10.1038/emboj.2010.223
46. Ki, C. S., Stavrou, E. F., Davanos, N., Lee, W. Y., Chung, E. J., Kim, J. Y.,et al. (2007). The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease. Clin. Genet. 71, 471-473. doi: 10.1111/j.1399-0004.2007.00781.x
47. Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., and Olanow, C. W. (2008). Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14, 504-506. doi: 10.1038/nm1747
48. Kordower, J. H., Dodiya, H. B., Kordower, A. M., Terpstra, B., Paumier, K., Madhavan, L.,et al. (2011). Transfer of host-derived alpha synuclein to grafted dopaminergic neurons in rat. Neurobiol. Dis. 43, 552-557. doi: 10.1016/j.nbd.2011.05.001
49. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S.,et al. (1998). Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108. doi: 10.1038/ng0298-106
50. Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z.,et al. (2006). Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 26, 11915-11922. doi: 10.1523/JNEUROSCI.3821-06.2006
51. Lee, H. J., Patel, S., and Lee, S. J. (2005). Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 6016-6024. doi: 10.1523/JNEUROSCI.0692-05.2005
52. Lee, H. J., Suk, J. E., Bae, E. J., Lee, J. H., Paik, S. R., and Lee, S. J. (2008a). Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 40, 1835-1849. doi: 10.1016/j.biocel.2008.01.017
53. Lee, H. J., Suk, J. E., Bae, E. J., and Lee, S. J. (2008b). Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem. Biophys. Res. Commun. 372, 423-428. doi: 10.1016/j.bbrc.2008.05.045
54. Lee, H. J., Suk, J. E., Patrick, C., Bae, E. J., Cho, J. H., Rho, S.,et al. (2010). Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262-9272. doi: 10.1074/jbc.M109.081125
55. Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honore, A., Rozas, N.,et al. (2013). G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459-471. doi: 10.1002/ana.23894
56. Li, J. Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J.,et al. (2008). Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503. doi: 10.1038/nm1746
57. Liu, G., Zhang, C., Yin, J., Li, X., Cheng, F., Li, Y.,et al. (2009). Alpha-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci. Lett. 454, 187-192. doi: 10.1016/j.neulet.2009.02.056
58. Loeb, V., Yakunin, E., Saada, A., and Sharon, R. (2010). The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition. J. Biol. Chem. 285, 7334-7343. doi: 10.1074/jbc.M109.061051
59. Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O'Brien, P., Trojanowski, J. Q.,et al. (2012a). Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949-953. doi: 10.1126/science.1227157
60. Luk, K. C., Kehm, V. M., Zhang, B., O'Brien, P., Trojanowski, J. Q., and Lee, V. M. (2012b). Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice.J. Exp. Med. 209, 975-986. doi: 10.1084/jem.20112457
61. Luk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R.,et al. (2009). Exogenous alpha-synuclein fibrils seed the formation of lewy body-like intracellular inclusions in cultured cells. Proc. Natl. Acad. Sci. U.S.A.106, 20051-20056. doi: 10.1073/pnas.0908005106
62. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988). Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
63. Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G.,Jenkins, N. A.,et al. (2006). Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41-50. doi: 10.1523/JNEUROSCI.4308-05.2006
64. Martinez-Vicente, M., and Vila, M. (2013). Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop. Exp. Neurol. 247, 308-313. doi: 10.1016/j.expneurol.2013.03.005
65. Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Kubo, M., Shimozawa, A., Akiyama, H., et al. (2014). Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol. Commun. 2:88. doi: 10.1186/s40478-014-0088-8
66. Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H.,et al. (2013). Prion-like spreading of pathological alpha-synuclein in brain. Brain 136(Pt 4), 1128-1138. doi: 10.1093/brain/awt037
67. Mendez, I., Vinuela, A., Astradsson, A., Mukhida, K., Hallett, P., Robertson, H.,et al. (2008). Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14, 507-509. doi: 10.1038/nm1752
68. Mougenot, A. L., Nicot, S., Bencsik, A., Morignat, E., Verchere, J., Lakhdar, L.,et al. (2012). Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225-2228. doi: 10.1016/j.neurobiolaging.2011.06.022
69. Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., and Lee, V. M. (2000). Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 20, 3214-3220.
70. Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K.,et al. (2011). Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J. Biol. Chem. 286, 20710-20726. doi: 10.1074/jbc.M110.213538
71. Navarro-Otano, J., Gelpi, E., Mestres, C. A., Quintana, E., Rauek, S., Ribalta, T.,et al. (2013). Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism. Parkinsonism Relat. Disord. 19, 27-31. doi: 10.1016/j.parkreldis.2012.07.005
72. Nonaka, T., Watanabe, S. T., Iwatsubo, T., and Hasegawa, M. (2010). Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J. Biol. Chem. 285, 34885-34898. doi: 10.1074/jbc.M110.148460
73. Pan-Montojo, F., Anichtchik, O., Dening, Y., Knels, L., Pursche, S., Jung, R.,et al. (2010). Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5:e8762. doi: 10.1371/journal.pone.0008762
74. Pan-Montojo, F., Schwarz, M., Winkler, C., Arnhold, M., O'Sullivan, G. A., Pal, A.,et al. (2012). Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci. Rep. 2:898. doi: 10.1038/srep00898
75. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A.,et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045
76. Puschmann, A., Ross, O. A., Vilarino-Guell, C., Lincoln, S. J., Kachergus, J. M., Cobb, S. A.,et al. (2009). A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat. Disord. 15, 627-632. doi: 10.1016/j.parkreldis.2009.06.007
77. Recasens, A., Dehay, B., Bove, J., Carballo-Carbajal, I., Dovero, S., Perez-Villalba, A.,et al. (2014). Lewy body extracts from Parkinson disease brains trigger alpha-synuclein pathology and neurodegeneration in mice and monkeys. Ann. Neurol. 75, 351-362. doi: 10.1002/ana.24066
78. Rey, N. L., Petit, G. H., Bousset, L., Melki, R., and Brundin, P. (2013). Transfer of human alpha-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathol. 126, 555-573. doi: 10.1007/s00401-013-1160-3
79. Reyes, J. F., Rey, N. L., Bousset, L., Melki, R., Brundin, P., and Angot, E. (2014). Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 62, 387-398. doi: 10.1002/glia.22611
80. Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P.,et al. (2008). Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem. 104, 1504-1525. doi: 10.1111/j.1471-4159.2007.05087.x
81. Sacino, A. N., Brooks, M., McKinney, A. B., Thomas, M. A., Shaw, G., Golde, T. E.,et al. (2014a). Brain Injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker. J. Neurosci. 34, 12368-12378. doi: 10.1523/JNEUROSCI.2102-14.2014
82. Sacino, A. N., Brooks, M., Thomas, M. A., McKinney,A. B., Lee, S., Regenhardt, R. W.,et al. (2014b). Intramuscular injection of alpha-synuclein induces CNS alpha-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 111, 10732-10737. doi: 10.1073/pnas.1321785111
83. Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., McGarvey, N. H., Rutherford, N. J.,et al. (2014c). Amyloidogenic alpha-synuclein seeds do not invariably induce rapid, widespread pathology in mice. Acta Neuropathol. 127, 645-665. doi: 10.1007/s00401-014-1268-0
84. Sato, H., Kato, T., and Arawaka, S. (2014). Potential of cellular and animal models based on a prion-like propagation of alpha-synuclein for assessing antiparkinson agents. Mol. Neurobiol. doi: 10.1007/s12035-014-8858-7 [Epub ahead of print].
85. Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., and Nicholson, G. A. (2001). Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann. Neurol. 49, 313-319. doi: 10.1002/ana.67
86. Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., and Chung, K. C. (2001). Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J. Biol. Chem. 276, 27441-27448. doi: 10.1074/jbc.M101318200
87. Sung, J. Y., Park, S. M., Lee, C. H., Um, J. W., Lee, H. J., Kim, J.,et al. (2005). Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J. Biol. Chem. 280, 25216-25224. doi: 10.1074/jbc.M503341200
88. Thayanidhi, N., Helm, J. R., Nycz, D. C., Bentley, M., Liang, Y., and Hay, J. C. (2010). Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol. Biol. Cell 21, 1850-1863. doi: 10.1091/mbc.E09-09-0801
89. Tran, H. T., Chung, C. H., Iba, M., Zhang, B., Trojanowski, J. Q., Luk, K. C.,et al. (2014). Alpha-synuclein immunotherapy blocks uptake and templated propagation of misfolded alpha-synuclein and neurodegeneration.Cell Rep. 7, 2054-2065. doi: 10.1016/j.celrep.2014.05.033
90. Ulusoy, A., Rusconi, R., Perez-Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen-Reichert, B.,et al. (2013). Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol. Med. 5, 1051-1059. doi: 10.1002/emmm.201302475
91. Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A.,et al. (2011). Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57-71. doi: 10.1016/j.neuron.2011.08.033
92. Wang, L., Das, U., Scott, D. A., Tang, Y., McLean, P. J., and Roy, S. (2014). Alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. biol. 24, 2319-2326. doi: 10.1016/j.cub.2014.08.027
93. Watts, J. C., Giles, K., Oehler, A., Middleton, L., Dexter, D. T., Gentleman, S. M.,et al. (2013). Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 110, 19555-19560. doi: 10.1073/pnas.1318268110
94. Waxman, E. A., and Giasson, B. I. (2010). A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J. Neurochem. 113, 374-388. doi: 10.1111/j.1471-4159.2010.06592.x
95. Zarranz, J. J., Alegre, J., Gomez-Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I.,et al. (2004). The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173. doi: 10.1002/ana.10795
96. Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L.,et al. (2005). Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533-542. doi: 10.1096/fj.04-2751com